Status:
COMPLETED
Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110)
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
In mid-February 2020, within the Oise (France) cluster, a case of COVID-19 disease caused by a SARS-CoV2 infection was described among the personnel of the Creail Air Force Base (BA110). This resulted...
Eligibility Criteria
Inclusion
- Active military or civilian defence personnel working on the Creil Air Force Base (BA110) during the period of interest (from February 1st 2020 to the end of the study)
Exclusion
- Contraindication to blood sampling
- Pregnant, parturient, breastfeeding woman
Key Trial Info
Start Date :
May 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2021
Estimated Enrollment :
1146 Patients enrolled
Trial Details
Trial ID
NCT04404270
Start Date
May 26 2020
End Date
March 13 2021
Last Update
July 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
24e antenne médicale de Creil
Creil, France, 60314